Tag: Clots
Pulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019
Age-adjusted mortality rate increased for men versus women and Black versus White patients
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
Findings seen among adults prescribed warfarin, DOACs beyond six months after acute venous thromboembolism
New Eligibility Criteria May Increase Endovascular Thrombectomy Rates
Findings based on several criteria in patients with ischemic stroke due to anterior circulation large vessel occlusions
Concerning CT Findings Increase Health Care Utilization With Low-Risk Pulmonary Embolism
However, no short-term adverse clinical outcomes seen for these patients versus low-risk patients without concerning findings
Anticoagulants Do Not Reduce Arterial Thrombotic Event Risk in Cancer
No reduction seen in risk of antithrombotic events but increased risk of major and minor bleeding
Benefits of Indefinite Anticoagulant Unclear After First VTE
Indefinite anticoagulation prevented recurrent VTE events, but induced major bleeding events
Catheter-Directed Thrombolysis Beneficial for Pulmonary Embolism
Systematic review showed risk for death and major bleeding complications was lower for catheter-directed thrombolysis than systemic thrombolysis
ASCO: Direct Oral Anticoagulant Therapy Feasible for Cancer Patients
Direct oral anticoagulants noninferior to low-molecular-weight heparin for venous thromboembolism prevention
Atopic Dermatitis Tied to Higher Venous Thromboembolism Risk
While absolute risk difference is small, higher risk seen for both deep vein thrombosis and pulmonary embolism
2015 to 2019 Saw Increase in ED Use of CTPA for Suspected Pulmonary Embolism
Increase in PE diagnosis and higher proportion of low-risk PEs, with lower proportion of ICU admissions